These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11779936)

  • 1. Diurnal variation in the intensity of anticoagulation in atrial fibrillation.
    García A; Marín F; Sánchez B; Roldán V; Marco P
    Stroke; 2002 Jan; 33(1):322-4. PubMed ID: 11779936
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of acenocoumarol on hemorheological parameters.
    Vayá A; Martínez M; Fernández A; Ripoll F; Moscardó F; Mira Y; Aznar J
    Clin Hemorheol Microcirc; 2001; 24(2):111-5. PubMed ID: 11381186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
    Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of unstable anticoagulation with acenocoumarol versus warfarin in atrial fibrillation.
    Bryk AH; Plens K; Undas A
    Cardiol J; 2017; 24(5):477-483. PubMed ID: 28353307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.
    Siegbahn A; Oldgren J; Andersson U; Ezekowitz MD; Reilly PA; Connolly SJ; Yusuf S; Wallentin L; Eikelboom JW
    Thromb Haemost; 2016 May; 115(5):921-30. PubMed ID: 26818781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral anticoagulant therapy on fibrinolysis parameters in chronic non-rheumatic atrial fibrillation.
    Roldán-Schilling V; Marín-Ortuño F; Marco-Vera P; Sogorb-Garri F
    Haematologica; 2000 Jul; 85(7):778-80. PubMed ID: 10897143
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of warfarin therapy on activated factor VII clotting activity.
    Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulation and stroke in atrial fibrillation.
    Epstein EF; Natarajan I
    N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674042
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands.
    Jacobs MS; van Leent MWJ; Tieleman RG; Jansman FGA; Cao Q; Postma MJ; van Hulst M
    J Med Econ; 2017 Dec; 20(12):1231-1236. PubMed ID: 28766370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulation and stroke in atrial fibrillation.
    Boos CJ
    N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674043
    [No Abstract]   [Full Text] [Related]  

  • 11. Better stability of acenocoumarol compared to warfarin treatment in one-year observational, clinical study in patients with nonvalvular atrial fibrillation.
    Kulo A; Kusturica J; Kapić E; Becić F; Rakanović-Todić M; Burnazović-Ristić L; Mehmedović A; Lepar O; Mulabegović N
    Med Glas (Zenica); 2011 Feb; 8(1):9-14. PubMed ID: 21263388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness and safety of oral anticoagulation treatment with acenocoumarol in non-valvular atrial fibrillation].
    Castro C; Bustos L; Ocampo R; Molina E; Cabrero P; Vergara R; Lanas F
    Rev Med Chil; 2017 Oct; 145(10):1243-1251. PubMed ID: 29488564
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulation for patients with non-valvular atrial fibrillation].
    Mizoguchi T; Yasaka M
    Nihon Rinsho; 2016 Apr; 74(4):627-33. PubMed ID: 27333751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Warfarin or acenocoumarol is better in the anticoagulant treatment of chronic atrial fibrillation?].
    Lengyel M;
    Orv Hetil; 2004 Dec; 145(52):2619-21. PubMed ID: 15724697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on Anticoagulation in Atrial Fibrillation.
    Amerena J; Ridley D
    Heart Lung Circ; 2017 Sep; 26(9):911-917. PubMed ID: 28684097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of acenocoumarol and aspirin on platelet function, markers of thrombinemia, and intracardiac thrombosis in patients with atrial fibrillation].
    Zharkova TV; Ataullakhanova DM; Bykova ES; Kropacheva ES; Dobrovol'skiĭ AB; Titaeva EV; Panchenko EP
    Kardiologiia; 2007; 47(6):31-6. PubMed ID: 18260872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
    J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New avenues for anticoagulation in atrial fibrillation.
    Mantha S; Cabral K; Ansell J
    Clin Pharmacol Ther; 2013 Jan; 93(1):68-77. PubMed ID: 23212107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial Fibrillation and Stroke: Making Sense of Recent Observations on Anticoagulation.
    Proietti M; Lip GY
    Cardiol Clin; 2016 May; 34(2):317-28. PubMed ID: 27150180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.